株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の腹腔鏡装置市場の概要

US Market Overview for Laparoscopic Devices 2017 - MedView

発行 iData Research Inc. 商品コード 561530
出版日 ページ情報 英文 136 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=112.11円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
米国の腹腔鏡装置市場の概要 US Market Overview for Laparoscopic Devices 2017 - MedView
出版日: 2017年09月01日 ページ情報: 英文 136 Pages
概要

当レポートでは、米国における腹腔鏡装置の市場について分析し、全体的な市場規模の動向見通し (販売量・収益額・平均価格、市場成長率など) や、部位別の詳細動向、主な市場促進・抑制要因、昨今の市場情勢、企業別の市場シェアなどを調査すると共に、市場の背景事情 (関連傷害の概要、整形外科・外傷治療装置市場全体の構造など) に関する情報も取りまとめてお届けいたします。

エグゼクティブ・サマリー

米国の腹腔鏡装置市場の概要

競争分析

市場の傾向

市場の発展

処置件数

分析対象の処置コード

分析対象市場

主要レポートの更新状況

過去のバージョン

分析手法

  • 分析範囲
  • IDATAの9段階の分析方法

疾患概要

  • イントロダクション
    • 婦人科系疾患
      • 婦人科系がん
      • 子宮筋腫
      • 子宮内膜症
      • 月経過多
      • 骨盤臓器脱
      • 子宮外妊娠
      • 子宮摘出
    • 消化管疾患
      • 胃がん
      • ヘルニア
      • 胆石発作
      • 肥満
    • 大腸疾患
      • 大腸がん
      • 炎症性腸疾患
      • 大腸憩室症

腹腔鏡装置の市場

  • イントロダクション
  • 市場概要
  • 市場動向の分析
  • 市場促進・抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 企業間市場シェアの分析
  • 市場動向
  • 新規技術
  • 企業プロファイル
    • Applied Medical
    • B. Braun Melsungen AG
    • Ethicon
    • Karl Storz
    • Medtronic
    • オリンパス
    • Richard Wolf
    • Stryker
  • SWOT分析:Ethicon、Karl Storz、Medtronic、Olympusの場合

略語一覧

付録:企業からのプレスリリース

  • イントロダクション
  • プレスリリース
    • B. Braun Aesculap (全6件)
    • Ethicon (全15件)
    • Karl Storz (全5件)
    • Medtronic (全4件)
    • オリンパス (全5件)
    • Richard Wolf (全4件)
    • Stryker (全9件)

図表一覧

目次
Product Code: iDATA_USLAP17_MV

The full report suite on the U.S. market for laparoscopic devices includes laparoscopes, access devices, hand instruments, insufflation devices, suction-irrigation devices, direct energy devices, ultrasonic energy devices, hand-assisted devices, closure devices, gastric bands, powered morcellators, and female sterilization devices.

General Report Contents:

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions

Laparoscopy has been practiced for almost a century. It is a minimally invasive surgical technique in which operations in the abdominal or pelvic cavities are performed through small incisions that are usually between 5 mm to 15 mm. Laparoscopic access devices, or trocars, facilitate the insertion of various instruments into the patients abdomen, allowing the surgeon to carry out the procedure. Laparoscopes are inserted through a port of access, often at the site of the umbilicus or subxyphoid, and are equipped to illuminate and display the peritoneal cavity to allow the surgical team to perform abdominal and pelvic surgeries. Depending on the type of procedure, the number of incisions will vary; the average is three to four incisions per procedure. These sites provide entrance for other laparoscopic devices to enter the body cavity. Various hand instruments such as scissors, dissectors and graspers are used for manipulating and maneuvering organs and tissue. Alternative devices using direct energy and ultrasonic energy may be used for grasping, cutting and coagulating the tissue.

Insufflators are used for pumping carbon dioxide in to the abdominal cavity to create a pneumoperitoneum in preparation for laparoscopic surgery. The pumping of the gas creates sufficient space within the abdominal cavity for insertion and manipulation of laparoscopic devices with an adequate optical field. Suction-irrigation pumps are used to regulate fluids during the operation. Upon completion of the surgery, closure devices are used to close vessels and other internal wounds to enhance hemostasis. Some procedures such as tubal ligation and certain bariatric procedures can involve the implantation of specialized devices designed specifically for an intended procedure. Specialized laparoscopic devices such as gastric bands and female sterilization implants are analyzed separately.

Clinical data clearly shows that while laparoscopic surgery is often more expensive to perform compared to open surgery, these heightened costs are outweighed by substantial benefits to the patient, including a reduced hospital stay, less scarring and a significantly shorter recovery period.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

U.S. LAPAROSCOPIC DEVICE MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURES COVERED

PROCEDURE CODES INVESTIGATED

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • 1.1. RESEARCH SCOPE
  • 1.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. INTRODUCTION
    • 2.1.1. Gynecological Conditions
      • 2.1.1.1. Gynecological Cancers
      • 2.1.1.2. Uterine Fibroids
      • 2.1.1.3. Endometriosis
      • 2.1.1.4. Menorrhagia
      • 2.1.1.5. Pelvic Prolapse
      • 2.1.1.6. Ectopic Pregnancy
      • 2.1.1.7. Hysterectomy
    • 2.1.2. Digestive Tract Conditions
      • 2.1.2.1. Stomach Cancer
      • 2.1.2.2. Hernia
      • 2.1.2.3. Gallbladder Attack
      • 2.1.2.4. Obesity
    • 2.1.3. Colorectal Conditions
      • 2.1.3.1. Colorectal Cancer
      • 2.1.3.2. Inflammatory Bowel Disease
      • 2.1.3.3. Diverticulitis

U.S. LAPAROSCOPIC DEVICE MARKET OVERVIEW

  • 3.1. INTRODUCTION
  • 3.2. MARKET OVERVIEW
  • 3.3. TREND ANALYSIS BY SEGMENT
  • 3.4. DRIVERS AND LIMITERS
    • 3.4.1. Market Drivers
    • 3.4.2. Market Limiters
  • 3.5. COMPETITIVE MARKET SHARE ANALYSIS
  • 3.6. MARKET TRENDS
  • 3.7. EMERGING TECHNOLOGIES
  • 3.8. COMPANY PROFILES
    • 3.8.1. Applied Medical
    • 3.8.2. B. Braun Melsungen AG
    • 3.8.3. Ethicon
    • 3.8.4. Karl Storz
    • 3.8.5. Medtronic
    • 3.8.6. Olympus
    • 3.8.7. Richard Wolf
    • 3.8.8. Stryker
  • 3.9. SWOT ANALYSIS
    • 3.9.1. Ethicon
    • 3.9.2. Karl Storz
    • 3.9.3. Medtronic
    • 3.9.4. Olympus

ABBREVIATIONS

APPENDIX: COMPANY PRESS RELEASES

  • 5.1. INTRODUCTION
  • 5.2. PRESS RELEASES
    • 5.2.1. B. Braun Aesculap
      • 5.2.1.1. Change in the B. Braun Management Board and the Aesculap Management Board
      • 5.2.1.2. B. Braun Launches Easypump® Home Infusion Therapy App For Healthcare Professionals and Patients
      • 5.2.1.3. B. Braun continues its sales and earnings growth
      • 5.2.1.4. Change in the B. Braun Management Board
      • 5.2.1.5. B. Braun Launches Prontosan® Wound Gel X
      • 5.2.1.6. B. Braun's growth trend continues
    • 5.2.2. Ethicon
      • 5.2.2.1. ETHICON ANNOUNCES 510(k) CLEARANCE FOR ECHELON CIRCULAR™ POWERED STAPLER
      • 5.2.2.2. ETHICON ANNOUNCES COMPLETION OF ACQUISITION OF TORAX MEDICAL, INC.
      • 5.2.2.3. ETHICON AND DEPUY SYNTHES INTRODUCE CUSTOMIZED WOUND CLOSURE KITS AIMING TO IMPROVE EFFICIENCIES AND PATIENT OUTCOMES IN ORTHOPAEDIC SURGERY
      • 5.2.2.4. New Data Shows ECHELON FLEX™ Powered Staplers Associated with Clinical And Economic Benefits Compared to Medtronic ENDO GIA™ Manual Staplers
      • 5.2.2.5. ETHICON LAUNCHES ENSEAL® X1 LARGE JAW TISSUE SEALER, ESTABLISHING NEXT GENERATION OF ADVANCED BIPOLAR DEVICES
      • 5.2.2.6. New England Journal of Medicine Publishes Five Year Data from Ethicon-Funded STAMPEDE Study
      • 5.2.2.7. THE ECHELON FLEX™ GST SYSTEM WILL NOW FEATURE A 45MM ENDOCUTTER WITH EXCLUSIVE GRIPPING SURFACE TECHNOLOGY RELOADS
      • 5.2.2.8. Ethicon Announces Acquisition of Megadyne Medical Products, Inc.
      • 5.2.2.9. ETHICON LAUNCHES HARMONIC® HD 1000i SHEARS TO ADDRESS CHALLENGES IN COMPLEX SURGICAL PROCEDURES
      • 5.2.2.10. ETHICON WIDENS COMPREHENSIVE ADVANCED ENERGY PORTFOLIO WITH ADDITION OF ENSEAL® X1 LARGE JAW TISSUE SEALER
      • 5.2.2.11. ETHICON ANNOUNCES STRATEGIC COLLABORATION WITH TOUCH SURGERY TO EVOLVE MEDICAL EDUCATION
      • 5.2.2.12. ETHICON ESTABLISHES UNMATCHED KNOTLESS SUTURE PORTFOLIO WITH LAUNCH OF STRATAFIX™ SPIRAL PLUS DEVICES
      • 5.2.2.13. ETHICON RECEIVES U.S. FOOD AND DRUG ADMINISTRATION 510(K) CLEARANCE FOR HARMONIC® HD 1000i SHEARS
      • 5.2.2.14. ETHICON'S HARMONIC ACE®+7 SHEARS PROVIDE RELIABLE SEALING, REQUIRE FEWER SURGICAL DEVICES IN COLECTOMY AND HYSTERECTOMY
      • 5.2.2.15. Ethicon Announces Completion Of Acquisition Of NeuWave Medical, Inc.
    • 5.2.3. Karl Storz
      • 5.2.3.1. KARL STORZ video laryngoscope awarded the German Innovation Award 2017
      • 5.2.3.2. KARL STORZ is partner of an EU-funded project
      • 5.2.3.3. KARL STORZ establishes new production building in Estonia
      • 5.2.3.4. KARL STORZ Installs Advanced Blue Light Cystoscopy System at Naval Medical Center San Diego
      • 5.2.3.5. Sybill Storz Honored as Pioneer in Endoscopy
    • 5.2.4. Medtronic
      • 5.2.4.1. Medtronic Signs Definitive Agreement to Divest a Portion of Its Patient Monitoring & Recovery Division to Cardinal Health for $6.1 Billion
      • 5.2.4.2. Medtronic Announces Worldwide Voluntary Field Corrective Action For Newport? HT70 and Newport? HT70 Plus Ventilators
      • 5.2.4.3. Medtronic Introduces Signia? Stapling System, Innovative Surgical Stapler for Minimally Invasive Surgery
      • 5.2.4.4. Medtronic Receives Expanded Indication From FDA for Pillcam? Colon 2 Capsule
    • 5.2.5. Olympus
      • 5.2.5.1. Sevenfold prizewinner: Olympus receives six iF Design Awards and one Red Dot Award. Medical technology and microscopy products particularly successful.
      • 5.2.5.2. Olympus ENDOCUFF Now FDA 510(k)-Cleared to Claim Improvement in Adenoma Detection Rate during Colonoscopy
      • 5.2.5.3. Olympus VISERA 4K UHD Receives "Excellence in Surgical Products Awards," Minimally Invasive Surgical Product Category
      • 5.2.5.4. Olympus Showcases Advancements and Milestones in EndoTherapy at ACG
      • 5.2.5.5. Double your energy, enhance safety and speed: Olympus THUNDERBEAT Type S is incorporating all-new Intelligent Tissue Monitoring for superior dissection with optimal temperature control
    • 5.2.6. Richard Wolf
      • 5.2.6.1. The new definition of sharp
      • 5.2.6.2. Richard Wolf establishes a new subsidiary company RIWOspine
      • 5.2.6.3. New flexibility in endoscopic imaging
      • 5.2.6.4. The new "blue" Standard for Photodynamic Diagnostics (PDD)
    • 5.2.7. Stryker
      • 5.2.7.1. Stryker reports 2016 results and 2017 outlook
      • 5.2.7.2. Stryker provides 2016 preliminary net sales results
      • 5.2.7.3. Stryker announces multi-year partnership with Indo UK Institute of Health to deliver affordable orthopaedic care in India
      • 5.2.7.4. Stryker acquires Stanmore Implants Worldwide Limited
      • 5.2.7.5. Stryker completes acquisition of Physio-Control International, Inc.
      • 5.2.7.6. Stryker completes acquisition of Sage Products, LLC
      • 5.2.7.7. Stryker Announces Definitive Agreement to Acquire Physio-Control International, Inc. for $1.28 Billion
      • 5.2.7.8. Stryker Announces Definitive Agreement to Acquire Sage Products, LLC from Madison Dearborn Partners for $2.775 Billion
      • 5.2.7.9. Stryker Announces the Retirement of William R. Jellison and the promotion of Glenn S. Boehnlein to Vice President, Chief Financial Officer

LIST OF CHARTS

  • Chart 1-1: Laparoscopic Device Market by Segment, U.S., 2013 - 2023
  • Chart 1-2: Laparoscopic Device Market Overview, U.S., 2016 & 2023
  • Chart 3-1: Laparoscopic Device Market by Segment, U.S., 2013 - 2023
  • Chart 3-2: Laparoscopic Device Market Breakdown, U.S., 2016
  • Chart 3-3: Laparoscopic Device Market Breakdown, U.S., 2023
  • Chart 3-4: Growth Rates by Segment, Laparoscopic Device Market, U.S., 2013 - 2023
  • Chart 3-5: Leading Competitors, Laparoscopic Device Market, U.S., 2016

LIST OF FIGURES

  • Figure 1-1: Laparoscopic Device Market Share Ranking by Segment, U.S., 2016 (1 of 3)
  • Figure 1-2: Laparoscopic Device Market Share Ranking by Segment, U.S., 2016 (2 of 3)
  • Figure 1-3: Laparoscopic Device Market Share Ranking by Segment, U.S., 2016 (3 of 3)
  • Figure 1-4: Companies Researched in this Report, U.S., 2016
  • Figure 1-5: Factors Impacting the Laparoscopic Device Market by Segment, U.S. (1 of 3)
  • Figure 1-6: Factors Impacting the Laparoscopic Device Market by Segment, U.S. (2 of 3)
  • Figure 1-7: Factors Impacting the Laparoscopic Device Market by Segment, U.S. (3 of 3)
  • Figure 1-8: Recent Events in the Laparoscopic Device Market, U.S., 2014 - 2017
  • Figure 1-9: Laparoscopic Device Procedures Covered, U.S., 2016 (1 of 2)
  • Figure 1-10: Laparoscopic Device Procedures Covered, U.S., 2016 (2 of 2)
  • Figure 1-11: Procedure Codes Investigated, U.S., 2016
  • Figure 1-12: Laparoscopic Device Markets Covered, U.S., 2016 (1 of 2)
  • Figure 1-13: Laparoscopic Device Markets Covered, U.S., 2016 (2 of 2)
  • Figure 1-14: Key Report Updates
  • Figure 1-15: Version History
  • Figure 3-1: Laparoscopic Device Market by Segment, U.S., 2013 - 2023 (US$M) (1 of 2)
  • Figure 3-2: Laparoscopic Device Market by Segment, U.S., 2013 - 2023 (US$M) (2 of 2)
  • Figure 3-3: Laparoscopic Device Market Growth by Segment, U.S., 2013 - 2023 (1 of 2)
  • Figure 3-4: Laparoscopic Device Market Growth by Segment, U.S., 2013 - 2023 (2 of 2)
  • Figure 3-5: Drivers and Limiters, Laparoscopic Device Market, U.S., 2016
  • Figure 3-6: Leading Competitors, Laparoscopic Device Market, U.S., 2016 (1 of 2)
  • Figure 3-7: Leading Competitors, Laparoscopic Device Market, U.S., 2016 (2 of 2)
  • Figure 3-8: SWOT Analysis, Karl Storz, 2017
  • Figure 3-9: SWOT Analysis, Medtronic, 2017
  • Figure 3-10: SWOT Analysis, Olympus, 2017
  • Figure 5-1: Press Release Summary
Back to Top